GTS Securities’s West Pharmaceutical WST Stock Holding History

GTS Securities’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-947	Closed	-$261K	–	1876
2025 Q4	$261K	Sell	947 -3,671	-79%	-$1M	0.01%	1134
2025 Q3	$1.21M	Buy	+4,618	New	+$1.12M	0.05%	337
2025 Q1	–	Sell	-689	Closed	-$226K	–	1623
2024 Q4	$226K	Sell	689 -1,156	-63%	-$364K	0.01%	1042
2024 Q3	$554K	Buy	+1,845	New	+$565K	﹤0.01%	2721
2024 Q1	–	Sell	-1,171	Closed	-$412K	–	4498
2023 Q4	$412K	Buy	+1,171	New	+$414K	﹤0.01%	2947

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities's WST Position: Q1 2026 in Review

GTS Securities sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 947 shares — an estimated $261K sold.

GTS Securities first reported a position in WST in Q4 2023 and held it in 5 quarters. The position peaked at $1.21M in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

GTS Securities reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
GTS Securities sold 947 West Pharmaceutical shares in Q1 2026, an estimated $261K.
GTS Securities first reported a position in West Pharmaceutical in Q4 2023 and held it in 5 quarters.
GTS Securities's West Pharmaceutical position peaked at $1.21M in Q3 2025.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.